143 related articles for article (PubMed ID: 12792864)
1. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci.
Miyoshi-Akiyama T; Zhao J; Kikuchi K; Kato H; Suzuki R; Endoh M; Uchiyama T
J Infect Dis; 2003 Jun; 187(12):1876-87. PubMed ID: 12792864
[TBL] [Abstract][Full Text] [Related]
2. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.
Shiseki M; Miwa K; Nemoto Y; Kato H; Suzuki J; Sekiya K; Murai T; Kikuchi T; Yamashita N; Totsuka K; Ooe K; Shimizu Y; Uchiyama T
Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465
[TBL] [Abstract][Full Text] [Related]
4. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.
Stevens DL; Salmi DB; McIndoo ER; Bryant AE
J Infect Dis; 2000 Oct; 182(4):1117-28. PubMed ID: 10979908
[TBL] [Abstract][Full Text] [Related]
6. Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters.
Byrne JL; Aagaard-Tillery KM; Johnson JL; Wright LJ; Silver RM
J Reprod Immunol; 2009 Oct; 82(1):74-83. PubMed ID: 19682751
[TBL] [Abstract][Full Text] [Related]
7. [Incidence and distribution of Streptococcus pyogenes type M in patients treated at the Dr. Fran Mihaljević Infectious Disease Clinic in Zagreb from 1990 to 1996].
Bejuk D; Begovac J
Acta Med Croatica; 2002; 56(3):85-91. PubMed ID: 12630338
[TBL] [Abstract][Full Text] [Related]
8. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
Eriksson BK; Andersson J; Holm SE; Norgren M
J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate.
Miyoshi-Akiyama T; Ikebe T; Watanabe H; Uchiyama T; Kirikae T; Kawamura Y
J Infect Dis; 2006 Jun; 193(12):1677-84. PubMed ID: 16703511
[TBL] [Abstract][Full Text] [Related]
10. [Detection of pyrogenic exotoxin SpeA, SpeB and SpeC genes in Chilean streptococci isolates and their association with clinical manifestations].
Ulloa MT; Giglio MS; Porte L; Santa Cruz A; McNab P; Fica A; Pinto ME; Kawaguchi K; Carmi A
Rev Med Chil; 2000 Jan; 128(1):27-34. PubMed ID: 10883519
[TBL] [Abstract][Full Text] [Related]
11. Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.
Unnikrishnan M; Cohen J; Sriskandan S
Microb Pathog; 2001 Sep; 31(3):109-14. PubMed ID: 11500096
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
Woischnik M; Buttaro BA; Podbielski A
Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
[TBL] [Abstract][Full Text] [Related]
13. Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray.
Vlaminckx BJ; Schuren FH; Montijn RC; Caspers MP; Fluit AC; Wannet WJ; Schouls LM; Verhoef J; Jansen WT
Infect Immun; 2007 May; 75(5):2603-11. PubMed ID: 17325055
[TBL] [Abstract][Full Text] [Related]
14. [Invasive Lancefield group A streptococcal infections in the Netherlands].
Vlaminckx BJ; Mascini EM; Schellekens JF
Ned Tijdschr Geneeskd; 2007 Jul; 151(30):1669-73. PubMed ID: 17725254
[TBL] [Abstract][Full Text] [Related]
15. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection.
Engleberg NC; Heath A; Miller A; Rivera C; DiRita VJ
J Infect Dis; 2001 Apr; 183(7):1043-54. PubMed ID: 11237829
[TBL] [Abstract][Full Text] [Related]
17. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
[TBL] [Abstract][Full Text] [Related]
18. Properties of metabolic substances produced by group A streptococcus from a food-borne epidemic.
Kanno T; Sakaguchi K; Fukuyama M; Suzuki J
J Infect Chemother; 2011 Aug; 17(4):462-7. PubMed ID: 21190121
[TBL] [Abstract][Full Text] [Related]
19. Binding of NAD
Velarde JJ; O'Seaghdha M; Baddal B; Bastiat-Sempe B; Wessels MR
mBio; 2017 Sep; 8(5):. PubMed ID: 28900022
[TBL] [Abstract][Full Text] [Related]
20. Specificity of streptolysin O in cytolysin-mediated translocation.
Meehl MA; Caparon MG
Mol Microbiol; 2004 Jun; 52(6):1665-76. PubMed ID: 15186416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
